Related Experiment Videos
Clinical molecular imaging with positron emission tomography
Azeem Saleem1, Natalie Charnley, Pat Price
1The University of Manchester Wolfson Molecular Imaging Centre, 27 Palatine Road, Withington, Manchester, M20 3JL, UK. azeem.saleem@manchester.ac.uk
European Journal of Cancer (Oxford, England : 1990)
|June 27, 2006
Summary
Positron emission tomography (PET) offers sensitive molecular imaging for evaluating cancer. This review covers current PET applications in oncology and its emerging roles in treatment planning and drug development.
Area of Science:
- Molecular imaging
- Oncology
- Medical diagnostics
Background:
- Molecular imaging enables in vivo assessment of molecules and biological processes.
- Positron emission tomography (PET) is a sensitive, quantitative imaging technique with growing clinical and experimental use.
Purpose of the Study:
- Review the principles and current applications of PET in oncology.
- Discuss the evolving role of PET in radiotherapy planning, drug development, and understanding neoplastic processes.
Main Methods:
- Literature review of Positron Emission Tomography (PET) principles and applications.
- Synthesis of current and emerging uses of PET in cancer research and clinical practice.
Main Results:
- PET is established for cancer staging, treatment response assessment, and prognostication.
- Emerging applications include radiotherapy planning, anti-cancer drug development, and evaluating neoplastic drivers.
Conclusions:
- PET is a valuable tool in oncology with expanding applications.
- Further research will enhance PET's role in personalized cancer care and therapy development.